Search results
Results from the WOW.Com Content Network
Bulimia nervosa, also known simply as bulimia, is an eating disorder characterized by binge eating (eating large quantities of food in a short period of time, often feeling out of control) followed by compensatory behaviors, such as vomiting, excessive exercise, or fasting to prevent weight gain.
Unlike bulimia nervosa, binge eating disorder doesn’t involve compensatory behaviors — i.e., people don’t tend to over-exercise, use laxatives, or make themselves vomit after binge eating.
Atypical bulimia nervosa In this sub-threshold version of BN, individuals meet all criteria for BN, with the exception of the frequency criterion: binge eating and inappropriate compensatory behaviors occur, on average, less than once a week and/or for fewer than 3 months. [2] Binge-eating disorder of low frequency and/or limited duration
UFED is an eating disorder that does not meet the criteria for anorexia nervosa, bulimia nervosa, binge eating disorder, or other eating disorders. [1] People with UFED can have similar symptoms and behaviors to those with anorexia and bulimia, and can face the same risks associated with those disorders. [2]
This is an accepted version of this page This is the latest accepted revision, reviewed on 12 February 2025. Mental illness characterized by abnormal eating habits that adversely affect health Medical condition Eating disorder Specialty Psychiatry, clinical psychology Symptoms Abnormal eating habits that negatively affect physical or mental health Complications Anxiety disorders, depression ...
Binge eating disorder (BED) is an eating disorder characterized by frequent and recurrent binge eating episodes with associated negative psychological and social problems, but without the compensatory behaviors common to bulimia nervosa, OSFED, or the binge-purge subtype of anorexia nervosa.
Lisdexamfetamine is an FDA-approved appetite suppressant drug that is indicated (i.e., used clinically) for the treatment of binge eating disorder. [19] The antidepressant fluoxetine is a medication that is approved by the Food and Drug Administration for the treatment of an eating disorder, specifically bulimia nervosa.
Where available, ICD-10 codes are listed. When codes are available both as a sign/symptom (R code) and as an underlying condition, the code for the sign is used. When there is no symptoms for a disease that a patient has, the patient is said to be asymptomatic.